S.boulardii and BB536 - Clinical Chart

Clinical Materials

Many chronic illnesses, autoimmune disease and disfunction, and pathogenic infections originate, and have treatment potential, within the GIT. Probiotics are well-known for their positive health effects in the GIT and beyond, particularly where strain-specific therapy is used to elicit targeted results.

The S.boulardii and B. longum BB536 Clinical Applications Chart provides detailed indications for therapeutic use of beneficial probiotics Sacchromyces boulardii and Bifidobacterium longum BB536. Clinically relevant dosing, duration and results are included, along with specified therapeutic actions for the independent S.boulardii and B. longum BB536 strains.

Downloadable PDF is available FREE from www.bioconceptengage.com.au